Iridex (IRIX) Cash from Financing Activities (2011 - 2026)
Iridex (IRIX) posted quarterly Cash from Financing Activities of -$1000.0 for Q2 2026, down 100.02% year-over-year from $6.0 million in Q2 2025, and up 96.3% quarter-over-quarter from -$27000.0 in Q1 2026.
Iridex (IRIX) Cash from Financing Activities (2011 - 2026) Analysis & Trends
Iridex's Cash from Financing Activities history runs 16 years deep, the most recent figure standing at -$1000.0 for Q2 2026.
- In Q2 2026, Cash from Financing Activities fell 100.02% year-over-year to -$1000.0; the TTM figure through Apr 2026 stood at -$76000.0 (down 100.88% YoY), while the FY2026 annual figure was $6.0 million, up 128.94% from the prior year.
- Cash from Financing Activities for Q2 2026 stood at -$1000.0, up from -$27000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $7.0 million in Q1 2022, with the low at -$218000.0 in Q4 2024.
- The 5-year median for Cash from Financing Activities is -$14000.0 (2025), against an average of $1.0 million.
- Peak annual rise in Cash from Financing Activities reached 11862.5% in 2024, while the deepest fall reached 584.44% in 2024.
- Iridex's Cash from Financing Activities stood at -$26000.0 in 2022, then surged by 273.08% to $45000.0 in 2023, then plunged by 584.44% to -$218000.0 in 2024, then soared by 84.4% to -$34000.0 in 2025, then surged by 97.06% to -$1000.0 in 2026.
- Business Quant data shows IRIX's Cash from Financing Activities at -$1000.0 in Q2 2026, -$27000.0 in Q1 2026, and -$34000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Iridex | 13.03 Mn | 8.35 Mn | 4.30 Mn | -38,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -1,000.00 |
| Apr 4, 2026 | -1,000.00 |
| Jan 3, 2026 | -27,000.00 |
| Jan 3, 2026 | -27,000.00 |
| Sep 27, 2025 | -34,000.00 |
| Sep 27, 2025 | -34,000.00 |
| Jun 28, 2025 | -14,000.00 |
| Jun 28, 2025 | -14,000.00 |
| Mar 29, 2025 | 6.04 Mn |
| Mar 29, 2025 | 6.04 Mn |
| Dec 28, 2024 | -218,000.00 |
| Dec 28, 2024 | -218,000.00 |
| Sep 28, 2024 | 2.82 Mn |
| Sep 28, 2024 | 2.82 Mn |
| Dec 30, 2023 | 45,000.00 |
| Dec 30, 2023 | 45,000.00 |
| Sep 30, 2023 | -24,000.00 |
| Sep 30, 2023 | -24,000.00 |
| Jul 1, 2023 | -63,000.00 |
| Jul 1, 2023 | -63,000.00 |